HIGHFDA DEVICE

Altruan GmbH Bisaf Strep A Self-Test Recalled for FDA Clearance Issue

Bisaf Strep A Self-Test from Altruan GmbH remains active in recall status after the FDA flagged lack of clearance. The Class II medical device was distributed nationwide in the United States. The hazard is lack of FDA clearance. Consumers should stop use immediately and follow manufacturer guidance.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
December 19, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
December 19, 2025
Hazard Level
HIGH
Brand
Altruan
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Altruan
Product type
Strep A Self-Test
Model numbers
AL-42153
Sold at
Unknown
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    December 19, 2025

  2. Reported by FDA DEVICE

    March 18, 2026

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Product not cleared by the FDA.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Altruan GmbH or your healthcare provider for instructions. Notification method: Other

About This Product

The Bisaf Strep A Self-Test is a home or point-of-care throat swab test intended to detect group A streptococcal antigens. It is marketed for rapid results and convenience.

Why This Is Dangerous

The hazard is regulatory rather than a device defect. Without FDA clearance, there is regulatory risk and potential questions about performance and reliability.

Industry Context

This recall is not described as part of a broader industry pattern in the provided data.

Real-World Impact

Consumers should stop using the device to avoid potential regulatory or performance concerns. No injuries reported yet.

Practical Guidance

How to identify if yours is affected

  1. Check Model No. AL-42153
  2. Check Lot Code 6952804827274
  3. No UDI listed

Where to find product info

Look on the device packaging for model and batch information.

What timeline to expect

Refunds or replacements timelines are not specified in the summary; follow manufacturer guidance and FDA updates.

If the manufacturer is unresponsive

  • Contact healthcare provider for guidance
  • Report to FDA if you suspect issues

How to prevent similar issues

  • Verify FDA clearance before purchasing medical tests
  • Purchase from reputable retailers
  • Check for updated recall notices

Documentation advice

Keep packaging, model and batch information, and recall notices for future reference.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Product: Bisaf Strep A Self-Test. Purpose: Detection of group A streptococcal antigens in throat swabs. Quantity: 188 units. Distribution: US nationwide. Manufacturer: Altruan GmbH. Model No.: AL-42153. Lot Code: 6952804827274. UDI: No UDI.

Reported Incidents

No injuries or incidents have been reported in the provided data.

Key Facts

  • FDA clearance not obtained
  • Model No. AL-42153
  • US nationwide distribution

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Brand
Model Numbers
AL-42153
Affected States
ALL
Report Date
March 18, 2026
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

Taro Pharmaceuticals Withdraws Diclofenac Sodium Gel Over Viscosity Issues

Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.

BEEKEEPER'S NATURALS USA
Microbial Contamination
Read more
Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more